CN Stock MarketDetailed Quotes
000710 Berry Genomics
- 9.79
- 0.000.00%
Not Open Nov 8 09:30 CST
3.46BMarket Cap-12283P/E (TTM)
0.00High0.00Low0lotVolume0.00Open9.79Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)353.52MShares16.4852wk High1.85P/B3.12BFloat Cap5.4052wk Low10.77Limit Up318.26MShs Float98.00Historical High8.81Limit Down0.00%Amplitude1.60Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Berry Genomics Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.95%821.35M | -12.67%529.51M | -19.38%235.66M | -8.90%1.32B | -11.58%922.31M | -15.07%606.31M | -23.67%292.3M | -1.57%1.45B | 2.39%1.04B | 11.87%713.89M |
| Refunds of taxes and levies | -98.76%63.25K | -98.75%63.25K | -73.39%61.6K | -92.78%5.06M | -92.72%5.09M | -92.56%5.05M | 869.66%231.45K | 218.77%70.09M | 3,108.45%69.93M | 3,624.63%67.92M |
| Net deposit increase | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | -69.14%3.36M | -0.53%3.29M | -45.65%1.93M | -68.98%7.11M | -35.03%10.88M | -47.23%3.31M | 43.72%3.55M | -47.92%22.92M | -40.28%16.74M | -74.25%6.28M |
| Cash inflows from operating activities | -12.10%824.77M | -13.31%532.87M | -19.73%237.66M | -13.60%1.33B | -16.95%938.27M | -22.00%614.67M | -23.18%296.08M | 0.25%1.54B | 7.71%1.13B | 18.62%788.08M |
| Goods services cash paid | -19.31%375.12M | -20.96%235M | -24.82%126.68M | -33.62%617.34M | -34.01%464.91M | -36.28%297.34M | -36.80%168.49M | 10.68%930.05M | 6.35%704.57M | 0.32%466.62M |
| Staff behalf paid | 1.01%243.3M | -4.21%165.24M | -1.01%85.48M | -0.01%323.63M | -2.88%240.87M | 2.41%172.51M | -5.13%86.35M | 5.13%323.68M | 2.09%248.03M | -1.69%168.45M |
| All taxes paid | 49.78%53.75M | 80.30%42.44M | 39.71%22.59M | -23.01%51.44M | -22.90%35.89M | -38.49%23.54M | -27.61%16.17M | -28.76%66.82M | -40.36%46.55M | -31.47%38.27M |
| Net loan and advance increase | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net lend capital | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -31.79%129.7M | -39.55%76.99M | -31.49%45.62M | 13.95%230.76M | 20.64%190.14M | 25.71%127.37M | 19.08%66.59M | -0.91%202.51M | -1.44%157.61M | -17.97%101.32M |
| Cash outflows from operating activities | -13.95%801.87M | -16.28%519.67M | -16.95%280.38M | -19.69%1.22B | -19.45%931.81M | -19.87%620.75M | -22.55%337.61M | 5.30%1.52B | 1.17%1.16B | -5.05%774.67M |
| Net cash flows from operating activities | 254.55%22.9M | 317.05%13.2M | -2.87%-42.72M | 424.14%111.01M | 123.94%6.46M | -145.31%-6.08M | 17.68%-41.53M | -77.48%21.18M | 71.43%-26.99M | 108.86%13.42M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | --0 | -97.03%600K | ---- | ---- | ---- | -17.50%20.22M | --23.58M | --23.58M |
| Cash received from returns on investments | ---- | ---- | --0 | --7M | --399.57K | ---- | ---- | --0 | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 315,751.90%309.5M | 3,585,673.22%286.5M | -72.41%1.68K | 46.90%127.11K | 256.27%97.99K | -61.05%7.99K | -69.53%6.09K | -79.68%86.53K | 470.04%27.5K | 20,414.51%20.51K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --1.71M | --0.85 | --0.85 |
| Cash received relating to other investing activities | ---- | --0 | --0 | --0 | --6.48M | --6.48M | --6.48M | --1.87M | ---- | ---- |
| Cash inflows from investing activities | 4,337.02%309.5M | 4,317.32%286.5M | -99.97%1.68K | -67.65%7.73M | -70.46%6.98M | -72.52%6.49M | -72.53%6.48M | -4.18%23.89M | 489,246.84%23.61M | 23,603,894.81%23.6M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -10.63%35.33M | 128.95%22.08M | 290.31%7.81M | -24.84%55.1M | -42.91%39.54M | -85.32%9.65M | -95.98%2M | -78.23%73.31M | -70.26%69.25M | -14.18%65.73M |
| Cash paid to acquire investments | --171.5M | --148.52M | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --40.8M | --27.02M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 526.33%247.63M | 1,948.66%197.62M | 290.31%7.81M | -24.84%55.1M | -42.91%39.54M | -85.32%9.65M | -95.98%2M | -80.31%73.31M | -74.21%69.25M | -41.48%65.73M |
| Net cash flows from investing activities | 290.00%61.87M | 2,912.49%88.88M | -274.23%-7.81M | 4.14%-47.37M | 28.66%-32.56M | 92.50%-3.16M | 117.11%4.48M | 85.78%-49.42M | 83.00%-45.64M | 62.50%-42.12M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from borrowing | -42.01%117M | 30.80%100M | -63.98%10M | -25.79%212.43M | 76.37%201.76M | 17.46%76.45M | -33.25%27.76M | 37.72%286.27M | -44.97%114.4M | -43.21%65.08M |
| Cash received relating to other financing activities | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash inflows from financing activities | -42.01%117M | 30.80%100M | -63.98%10M | -25.79%212.43M | 76.37%201.76M | 17.46%76.45M | -33.25%27.76M | 8.30%286.27M | -56.72%114.4M | -61.95%65.08M |
| Borrowing repayment | 38.63%296.79M | 229.68%239.79M | 51.18%47.76M | -24.64%255.7M | -4.30%214.1M | -46.76%72.74M | -14.65%31.59M | 70.45%339.28M | 56.90%223.72M | 49.05%136.62M |
| Dividend interest payment | -33.91%7.71M | -17.93%6.37M | -18.97%3.08M | -45.21%15.5M | -51.36%11.67M | -17.02%7.76M | -18.65%3.8M | 39.34%28.29M | 73.98%23.99M | 6.85%9.35M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash payments relating to other financing activities | --11M | --6.3M | --0 | --8.52M | ---- | --0 | ---- | --0 | ---- | ---- |
| Cash outflows from financing activities | 39.75%315.51M | 213.64%252.46M | 43.65%50.84M | -23.90%279.71M | -8.86%225.77M | -44.86%80.49M | -15.09%35.4M | 67.47%367.57M | 57.36%247.71M | 44.08%145.97M |
| Net cash flows from financing activities | -727.01%-198.51M | -3,672.43%-152.46M | -435.16%-40.84M | 17.24%-67.29M | 81.99%-24M | 95.00%-4.04M | -7,940.95%-7.63M | -281.32%-81.3M | -224.71%-133.32M | -215.95%-80.88M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -126.35%-842.26K | -87.11%491.69K | 91.29%-97.78K | -86.59%1.5M | -74.80%3.2M | -33.97%3.81M | -4.72%-1.12M | 519.05%11.19M | 1,530.99%12.68M | 615.68%5.78M |
| Net increase in cash and cash equivalents | -144.27%-114.59M | -426.99%-49.89M | -99.72%-91.47M | 97.81%-2.15M | 75.73%-46.91M | 90.88%-9.47M | 41.14%-45.8M | 53.45%-98.35M | 24.80%-193.26M | 46.82%-103.81M |
| Add:Begin period cash and cash equivalents | -5.23%316.13M | -0.68%316.13M | 1.38%338.15M | -23.61%318.28M | -19.94%333.56M | -23.61%318.28M | -20.18%333.56M | -33.65%416.62M | -33.80%416.62M | -33.65%416.62M |
| End period cash equivalent | -29.69%201.54M | -13.79%266.24M | -14.28%246.68M | -0.68%316.13M | 28.34%286.65M | -1.28%308.81M | -15.38%287.76M | -23.61%318.28M | -40.01%223.36M | -27.71%312.81M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data